References
- Graves R. Newly observed affection of the thyroid gland
in females (Clinical lectures). London Medical and Surgical Journal (Renshaw).
1835; 7(2): 516-7.
- Parry CH. Collections from the unpublished medical
writings of the late Caleb Hillier Parry. London: Underwoods. 1825; 1:
2.
- Legge RI. Parry and Parry's disease. Res Medica.
1961; 2(4):33-7.
- Ogbera AO, Kuku SF. Epidemiology of thyroid diseases in Africa. Indian J Endocrinol Metab. 2011 Jul;15(Suppl 2):S82-8. PubMed | Google Scholar
- Ogbera A, Okosieme O. Thyroid diseases in Africa:
epidemiology and management challenges. Thyroid International. 2014;1.
- Kalk WJ, Kalk J. Incidence and causes of hyperthyroidism in blacks. S Afr Med J. 1989 Feb 04;75(3):114-7. PubMed | Google Scholar
- Franklyn JA. The management of hyperthyroidism. N Engl J Med. 1994 Jun 16;330(24):1731-8. PubMed | Google Scholar
- Melmed S, Polonsky K, Larsen PR, Kronenberg H. Williams
Textbook of Endocrinology. Philadelphia: Elsevier/Saunders. 2011.
- Werner SC, Ingbar SH, Braverman LE, Utiger RD. Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text. Philadelphia: Lippincott-Raven. 1996. Google Scholar
- Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39-51. PubMed | Google Scholar
- Davies TF, Ando T, Lin RY, Tomer Y, Latif R. Thyrotropin receptor-associated diseases: from adenomata to Graves disease. J Clin Invest. 2005 Aug;115(8):1972-83. PubMed | Google Scholar
- Bech K. Yersinia enterocolitica and thyroid autoimmunity. Autoimmunity. 1990;7(4):291-4. PubMed | Google Scholar
- Wolf MW, Misaki T, Bech K, Tvede M, Silva JE, Ingbar SH. Immunoglobulins of patients recovering from Yersinia enterocolitica infections exhibit Graves' disease-like activity in human thyroid membranes. Thyroid. 1991 Winter;1(4):315-20. PubMed | Google Scholar
- Davies TF, Greenberg D, Tomer Y. The genetics of the autoimmune thyroid diseases. Annales d'endocrinologie. 2003 Feb;64(1):28-30. PubMed | Google Scholar
- Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev. 2003 Dec;24(6):802-35. PubMed | Google Scholar
- Brent GA. Clinical practice: Graves' disease. N Engl J Med. 2008 Jun 12;358(24):2594-605. PubMed | Google Scholar
- Bartalena L, Marcocci C, Tanda ML, Piantanida E,
Lai A, Marino M et al. An update on medical management of Graves' ophthalmopathy.
J Endocrinol Invest. 2005 May;28(5):469-78. PubMed | Google
Scholar
- Glinoer D, Hesch D, Lagasse R, Laurberg P. The management of hyperthyroidism due to Graves' disease in Europe in 1986: Results of an international survey. Acta endocrinologica Supplementum. 1987;285:3-23. PubMed | Google Scholar
- Wartofsky L, Glinoer D, Solomon B, Nagataki S,
Lagasse R, Nagayama Y et al. Differences and similarities in the diagnosis
and treatment of Graves' disease in Europe, Japan, and the United States.
Thyroid. 1991;1(2):129-35. PubMed | Google
Scholar
- Silberstein EB, Ryan J. Prevalence of adverse reactions in nuclear medicine: pharmacopeia Committee of the Society of Nuclear Medicine. J Nucl Med. 1996 Jan;37(1):185-92. PubMed | Google Scholar
- Bartalena L. Diagnosis and management of Graves disease: a global overview. Nat Rev Endocrinol. 2013 Dec;9(12):724-34. PubMed | Google Scholar
- Acharya SH, Avenell A, Philip S, Burr J, Bevan JS, Abraham P. Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review. Clin Endocrinol (Oxf). 2008 Dec;69(6):943-50. PubMed | Google Scholar
- Traisk F, Tallstedt L, Abraham-Nordling M, Andersson
T, Berg G, Calissendorff J et al. Thyroid-associated ophthalmopathy after
treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.
J Clin Endocrinol Metab. 2009 Oct;94(10):3700-7. PubMed | Google
Scholar
- Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell'Unto
E, Bartolomei MP et al. Cigarette smoking and treatment outcomes in Graves
ophthalmopathy. Ann Intern Med. 1998 Oct 15;129(8):632-5. PubMed | Google
Scholar
- IBM Corp. Released 2012. IBM SPSS Statistics for
Windows, Version 21.0. Armonk, NY: IBM Corp.
- Blahd WH, Hays MT. Graves' disease in the male: a review of 241 cases treated with an individually calculated dose of sodium iodide I 131. Arch Intern Med. 1972 Jan;129(1):33-40. PubMed | Google Scholar
- Onimode YA, Adedapo KS, Dairo MD. Ophthalmic manifestation
as adverse factor for cure in radioiodine treatment
of Graves' disease. Thyroid Res Pract. 2017; 14(1):18-21. Google
Scholar
- Allahabadia A, Daykin J, Holder RL, Sheppard MC, Gough SC, Franklyn JA. Age and gender predict the outcome of treatment for Graves' hyperthyroidism. J Clin Endocrinol Metab. 2000 Mar;85(3):1038-42. PubMed | Google Scholar
- Sawin CT, Becker DV. Radioiodine and the treatment of hyperthyroidism: the early history. Thyroid. 1997 Apr;7(2):163-76. PubMed | Google Scholar
- Ross DS. Radioiodine therapy for hyperthyroidism. N Engl J Med. 2011 Feb 10;364(6):542-50. PubMed | Google Scholar
- Wartofsky L. Radioiodine therapy for Graves' disease: case selection and restrictions recommended to patients in North America. Thyroid. 1997 Apr;7(2):213-6. PubMed | Google Scholar
- Nordyke RA, Gilbert FI Jr. Optimal iodine-131 dose
for eliminating hyperthyroidism in Graves' disease. J Nucl Med. 1991
Mar;32(3):411-6. PubMed | Google
Scholar
- Gomez N, Gomez JM, Orti A, Gavalda L, Villabona
C, Leyes P et al. Transient hypothyroidism after iodine-131 therapy for
Grave's disease. J Nucl Med. 1995 Sep;36(9):1539-42. PubMed | Google
Scholar
- Sheehan MT, Doi SA. Transient Hypothyroidism after
Radioiodine for Graves' disease: challenges in Interpreting
thyroid Function Tests. Clin Med Res. 2016 Mar;14(1):40-5. PubMed | Google
Scholar
- Gomez JM, Virgili N, Soler J, Fernandez M, Montana E. Transient hypothyroidism after iodine-131 treatment of Graves' disease. Thyroidology. 1989 Dec;1(3):149-52. PubMed | Google Scholar
- Berg GE, Michanek AM, Holmberg EC, Fink M. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements. J Nucl Med. 1996 Feb;37(2):228-32. PubMed | Google Scholar
- Berg G, Michanek A, Holmberg E, Nyström E. Clinical outcome of radioiodine treatment of hyperthyroidism: a follow-up study. Journal of Internal Medicine. 1996;239(2):165-71. PubMed | Google Scholar
- Onimode YA, Ankrah A, Adedapo KS. Outcome of Radioiodine Therapy in a West African Population. World J Nucl Med. 2016 Jan-Apr;15(1):24-9. PubMed | Google Scholar